Table 7.
Count of Trichinella spiralis encysted larvae per gram muscle at 35 days post-infection
| Muscular phase | GII: Control-Positive | GIII: Abz-treated | GIV: CR n-BuOH fr. treated | GV: Com of Abz + CR n-BuOH fr | |
|---|---|---|---|---|---|
| Mean ± SD | 3520.0 ± 432.4 | 839.6 ± 49.8 | 1236.0 ± 68.8 | 682.0 ± 34.2 | |
| aP-value | - | 0.001** | 0.001** | 0.001** | |
| ANOVA | bP-value = 0.001** | ||||
|
Post hoc test Dunnett T3 cP-value |
GII: | - | 0.001** | 0.001** | 0.001** |
| GIII: | - | - | 0.001** | 0.003** | |
| GIV: | - | - | - | 0.001** | |
| GV: | - | - | - | - | |
| % of Efficacy | 76% | 65% | 81% | ||
T. spiralis larvae count was represented as mean ± SD, while the efficacy was represented as percentage depending on the following low %:
Efficacy = [(Mean count in the infected control group − Mean count in the study group) / Mean count in the infected control group] × 100
ap-value is significantly different from the control based on the Student’s t-test
bp-value is significantly different when comparing groups based on the one-way ANOVA test
cp-value significantly differs between groups depending on a post hoc test (Dunnett T3)
*p-value < 0.05 is significant
**p-value < 0.01 is highly significant